Research & Development: Page 94
-
The PharmaVOICE 100 - Letter from the Editor
The PharmaVOICE 100 was inspired by the men and women who graciously consent to share their insights on the various trends and challenges facing the life-sciences industry on a monthly basis. We are continually fired up by their knowledge and willingness to raise their voices and bring their uniq...
By Taren Grom • Jan. 2, 2008 -
Table of Contents
Table of Contents The Commanders and Chiefs From the presidents of major pharmaceutical companies to top executives at specialty and biotechnology companies to the leaders of companies that support the industry, these men and women are shaping the life-sciences industry. The Risk Takers The archi...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Stock via Getty ImagesTrendlineClinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
The Commanders and Chiefs
PharmaVOICE 100 These top-level executives are at the forefront, leading change within the industry and guiding their companies to success. Guided by Values David Mott It has been said that how individuals respond to adversity often defines their character. David Mott, president, CEO, and vice ch...
By PharmaVoice Team • Jan. 2, 2008 -
The Risk Takers
Taking the World by Storm Five years ago, during a cab ride in New York City the idea for the Institute for OneWorld Health, the nation’s only nonprofit pharmaceutical company, was born. The African cabbie’s comment that pharmaceutical companies have all the money ignited the fire. The passenger ...
By PharmaVoice Team • Jan. 2, 2008 -
What's New
Dorland Launches inRx Medical Education Independent company formed to respond to increasing regulatory standards. In response to growing concerns about regulatory oversight and the need to separate continuing medical-education programs from company-sponsored marketing activities, Dorland has crea...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaTrax
PharmaTrax Worldwide Hormonal Contraceptive Market to Increase The world market for hormonal contraceptive products will surpass $6 billion in 2005, according to a new report from Kalorama Information. The report, Markets in Human Reproductive Medicine: Contraception and Infertility Management, c...
By PharmaVoice Team • Jan. 2, 2008 -
Richard Pascoe -- An Officer & A Leader
An Officer & A Leader July 2005 From the military to the semiconductor industry to the life-sciences industry, Richard Pascoe has drawn on his leadership skills — team building and staff motivation, combined with courage, integrity, and character — to bring out the best in his people for the ...
By Kim Ribbink • Jan. 2, 2008 -
Table of Contents
Teri Cox says the public isn’t aware of the industry’s role in patient advocacy. Dr. Paul Bleicher says it’s important to consider what components of a CRO will be used when determining budgets. Contents Richard Pascoe says leadership is understanding what motivates people. July 2005 On the Cover...
By PharmaVoice Team • Jan. 2, 2008 -
Raise Your Voice -- Letters
Letters Are Drug Safety Concerns Endangering Drug Benefits? The best way to avoid draconian restrictions on consumer and doctor access to the world’s most innovative medicines is to strike an appropriate balance between benefits and risks. — Rob Norton A Congressional overreaction For starters, I...
By PharmaVoice Team • Jan. 2, 2008 -
Letter from the Editor
Communicating cooperatively Letter from the Editor July 2005 In June, an unprecedented number of exhibitors and attendees convened in Washington, D.C., to attend the annual Drug Information Association (DIA) conference. The DIA annual meeting provides a neutral forum for regulators, academics, an...
By PharmaVoice Team • Jan. 2, 2008 -
Talent Pool
Talent Pool July 2005 Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Dr. Marcus Carr Novo Nordisk Names Chief Medical Officer Marcus Carr, M.D., Ph.D., has joined Novo Nordisk as chief medical officer and executive director for clinical research of the hemostasis gro...
By PharmaVoice Team • Jan. 2, 2008 -
On the Calendar
July 18-19 The 2nd Annual Strategic Medicare Compliance and Administration Summit Ritz Carlton Hotel, Tysons Corner, Va. For more information, contact Jon Stock, The Center for Business Intelligence, at 800-817-8601, e-mail [email protected], or visit cbinet.com. July 18-19 9th International Out...
By PharmaVoice Team • Jan. 2, 2008 -
Table of Contents
Table of Contents Letter from the Editor Forum on Marketing Modern Marketing in the Making: Marketing executives from pharmaceutical, biotechnology, device, and diagnostic companies, ranging in size from small specialty to midtier to large and global, share common challeng...
By PharmaVoice Team • Jan. 2, 2008 -
On the Calendar
Industry Events October 15-16, 2003, Wardman Park Marriott Hotel — Washington, D.C. eSubmissions for Global Compliance This Marcus Evans conference will focus on electronic document management and publishing. Key topics will include an ICH update, changes in eCTD specifications, CDISC data standa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaCounsel
The Effects of the HIPAA Privacy Policy Rule on Clinical Research and Registries On April 14, 2003, the privacy rule took effect and most covered entities must now comply with its provisions. The rule establishes minimum federal standards for safeguarding the privacy of individually identifiable ...
By PharmaVoice Team • Jan. 2, 2008 -
E-Media
Dendrite Launches Sample Program Dendrite International Inc. has launched its One-Source Sample program, which serves the entire life cycle of sample-product promotion and blends market-leading software applications with best-in-class consulting and professional services. Helping to ensure compli...
By PharmaVoice Team • Jan. 2, 2008 -
E-Clinical Services: The Evolving Role of the Technology Vendor
The E-Arena etrials Worldwide Inc. With the extensive e-clinical options available to trial sponsors, as well as the continued advancement of technology, there is no question that careful consideration must be given to what tools to employ in clinical-trial research. But choosing a solution d...
By PharmaVoice Team • Jan. 2, 2008 -
Site Qualification and Training: Immediate Time, Cost, and Performance Improvements
ePharmaLearning Inc. ePharmaLearning Inc., Conshohocken, Pa., is an industry leading site qualification, clinical e-learning, and site activation company. For more information, visit epharmalearning.com. The keys to improving a clinical trial’s operational success include selecting the b...
By PharmaVoice Team • Jan. 2, 2008 -
Timely Enrollment and Retention: Keys to a Successful Clinical Trial
Ultimately, trial enrollment will always require extensive human interaction between all interested parties. Tools that can facilitate the magic that occurs when new methods of treatment get to market can change lives. Key to a successful clinical trial is timely enrollm...
By PharmaVoice Team • Jan. 2, 2008 -
Clinical Teams Say Sites Can Do Recruitment, But Can They?
Clinical Teams Say Sites Can Do Recruitment, But Can They? Why a fixed budget for every site sets up a study for failure. Patient Recruitment The best strategy is to customize recruitment campaigns to ensure that recruitment is timely and cost-effective. El...
By PharmaVoice Team • Jan. 2, 2008 -
Five Steps to Successful Electronic Data Management Vendor Selection
While the pharmaceutical industry has been working to adopt e-clinical technology for more than a decade, almost 70% of e-clinical technology implementations fail to meet expectations. Why the lack of success? There are countless reasons, but one of the most important is the complexity surroundin...
By PharmaVoice Team • Jan. 2, 2008 -
Investigator Initiated Trials: The 800-Pound Gorilla
The Clinical-Trial Process Investigator initiated trials (IITs) can be a significant boon to a company with a new drug or device or sometimes even an older product. Why? Because physicians are engaging in something they truly want to do (it’s their idea, after all), at a cost that’s generally ...
By PharmaVoice Team • Jan. 2, 2008 -
Improving Clinical-Trial Performance
The Clinical-Trial Process Improving Clinical-Trial Performance Effectively managing the vast number of dispersed resources involved in conducting a clinical trial requires a cohesive approach that assures clinical study and regulatory knowledge to achieve hig...
By PharmaVoice Team • Jan. 2, 2008 -
Clinical Document Development: Planning for Accelerated Timelines
Jean Hosutt, Ph.D., Director, Medical Regulatory Writing Clinical Document Development: Planning for Accelerated Timelines clinical document development Active planning is required to facilitate the partnership between the sponsor and medical-writing contractor resultin...
By PharmaVoice Team • Jan. 2, 2008 -
Clinical Data Strategies for Performance Optimization
Octagon Research Solutions Inc. Data Standards Organizations that hesitate to embrace these standards as opportunities will be at a competitive disadvantage. They will continue to struggle with the tactical “cost” of transforming the ...
By PharmaVoice Team • Jan. 2, 2008